alpelisib
novartis
['alpelisib', 'breast']
#asco22 | abstract presentation | sat 2:51pm cdt
alpelisib (alp) + fulvestrant (ful) in patients (pts) with hormone receptor positive (hr+), human epidermal growth factor receptor 2 negative (her2 ) advanced breast cancer....
presenter: dejan juric, md 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.